id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-D-0356-0008,FDA,FDA-2006-D-0356,"Ethicon, Inc. - Extension",Other,EXT-Request for Extension Comment Due Date,2009-02-12T05:00:00Z,2009,2,2009-02-12T05:00:00Z,,2013-07-27T20:44:43Z,,0,0,090000648045f6c6
FDA-2006-D-0356-0004,FDA,FDA-2006-D-0356,Draft Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Availability; Reopening of Comment Period,Notice,NEC-Notice of Extension,2008-09-11T04:00:00Z,2008,9,2008-09-11T04:00:00Z,2008-10-15T03:59:59Z,2024-11-12T04:19:51Z,E8-21197,1,0,09000064806ff38c
FDA-2006-D-0356-0003,FDA,FDA-2006-D-0356,Draft Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Availability; Reopening of Comment Period,Notice,NEC-Notice of Extension,2007-05-09T04:00:00Z,2007,5,2007-05-07T04:00:00Z,2007-06-08T03:59:59Z,2008-10-10T21:37:44Z,,0,0,090000648045f6e6
FDA-2006-D-0356-0001,FDA,FDA-2006-D-0356,Draft Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Availability,Notice,NAD-Notice of Availability of Data,2006-10-31T05:00:00Z,2006,10,2006-10-30T05:00:00Z,2007-01-30T04:59:59Z,2008-10-10T21:42:17Z,,0,0,090000648045f6a0
FDA-2006-D-0356-0002,FDA,FDA-2006-D-0356,Draft Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Draft Guidance Document,Other,GDL-Guidance (Supporting and Related Materials),2006-10-31T05:00:00Z,2006,10,2006-10-31T22:45:53Z,,2008-10-10T21:45:55Z,,0,0,090000648045f6b9